Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. E. J. Murphy, M. Spears, I. Donnelly, L. Jolly, J. Thompson, J. Lafferty, E. Cameron, R. Chaudhuri, C. McSharry, M. C. Shepherd, N. C. Thomson (Glasgow, United Kingdom). Serum soluble ST2 is corticosteroid sensitive in asthma. Eur Respir J 2010; 36: Suppl. 54, 4308

Member's Comments

No comment yet.

Related content which might interest you: Serum level of soluble interleukin-2 receptors (sIL-2R) during acute asthma exacerbation, and its relation to severity and response to bronchodilator therapy Source: Eur Respir J 2002; 20: Suppl. 38, 141s Year: 2002 Serum leptin levels in asthmatic children treated with inhaled corticosteroid Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004 Elevated serum IgE, oral corticosteroid dependence and IL-17/22 expression in highly neutrophilic asthma Source: Eur Respir J, 54 (5) 1900068; 10.1183/13993003.00068-2019 Year: 2019 The effects of inhaled steroids, leukotriene receptor antagonists and theophylline on induced sputum cell counts, serum and sputum ECP levels in mild persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001 Serum levels of interleukin-18 in patients affected by allergic bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 30s Year: 2002 Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Serum levels of IL-8, IL-10 and TNFα in severe allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005 Correlation between specific serum IgE and exhaled NO levels at low and high inhaled corticosteroid use in allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005 Serum eosinophil cationic protein as a potential biomarker for interleukin-5 antibody treatment in patients with severe uncontrolled eosinophilic asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Serum Surfactant Protein D is decreased by oral steroids in asthma but not COPD Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018 Effect of montelukast administration on serum IL-5 and total IgE levels in asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004 Influence of inhaled steroids on serum interleukin-5 and interleukin-13 in an adult population of stable asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 291s Year: 2003 Elevated serum IL-12 and IL-18 levels in patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 424s Year: 2002 Serum TNFα and IL8 as markers of systemic inflammation in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005 Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation Source: Eur Respir J, 59 (2) 2100142; 10.1183/13993003.00142-2021 Year: 2022 Monitoring free serum IgE in severe asthma patients treated with omalizumab Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 The effect of montelukast and triamcinolon on clinical parameters and serum levels of ECP, sIL-2R and IL-4 in children with moderate asthma Source: Eur Respir J 2001; 18: Suppl. 33, 123s Year: 2001 Serum high sensitivity C-reactive protein can distinguish cough-variant and bronchial asthma Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008 Monitoring free serum IgE in asthma patients treated with omalizumab Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010